NWANX | VIVIX | NWANX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 26 years | - |
Gain YTD | 21.666 | 19.003 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 658M | 184B | 0% |
Annual Yield % from dividends | 1.71 | 2.37 | 72% |
Returns for 1 year | 27.59 | 29.29 | 94% |
Returns for 3 years | -1.74 | 22.51 | -8% |
Returns for 5 years | N/A | 53.41 | - |
Returns for 10 years | N/A | 113.86 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PASIX | 11.32 | -0.04 | -0.35% |
PACE Alternative Strategies A | |||
PEMCX | 13.75 | -0.06 | -0.43% |
Principal Edge MidCap A | |||
ERHSX | 15.70 | -0.22 | -1.38% |
Eaton Vance Worldwide Health Sci R | |||
ARTKX | 49.46 | -0.76 | -1.51% |
Artisan International Value Investor | |||
BDBPX | 27.09 | -0.49 | -1.78% |
iShares Russell 2000 Small-Cap Idx Inv P |